ZEPP R&D to Revenue
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares · R&D to Revenue
ZEPP R&D to Revenue
Latest reported18.17%period ending
ZEPP Quarterly R&D/Revenue (11.37% → 18.17%)
Latest values, visible window
High-resolution chart · PNG
ZEPP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 18.1739% | |
| 0% | |
| 12.895% | |
| 14.2527% | |
| 18.7809% | |
| 32.1172% | |
| 18.5768% | |
| 25.5735% | |
| 26.6178% | |
| 33.5886% | |
| 13.4013% | |
| 12.3971% | |
| 13.7725% | |
| 18.2699% | |
| 10.6688% | |
| 10.5642% | |
| 11.6388% | |
| 19.3393% | |
| 5.644% | |
| 6.7658% | |
| 8.7352% | |
| 13.2777% | |
| 6.569% | |
| 7.7353% | |
| 10.306% | |
| 10.8719% | |
| 6.6379% | |
| 6.6865% | |
| 9.0257% | |
| 9.0521% | |
| 6.9469% | |
| 5.579% | |
| 5.8351% | |
| 12.6021% | |
| 6.0104% | |
| 7.4344% | |
| 6.6881% | |
| 12.2324% | |
| 5.5951% | |
| 9.8896% | |
| 11.3743% |